Grupo Cibest S.A.
NYSEJP Morgan's downgrade of CIB has coincided with a notable build in short positions. The Colombian bank's NYSE-listed shares now sit at $98.23 — below both analyst targets and the stock's own recent highs. The same JP Morgan analyst who upgraded Grupo Cibest S.A. to Overweight in August — raising the target to $110 from $70 — reversed course this week. Yuri…
CIB short interest jumps 38% in one month as JP Morgan downgrades to Neutral, maintaining $110 target despite stock trading at $98.32.
JP Morgan's downgrade of CIB has coincided with a notable build in short positions. The Colombian bank's NYSE-listed shares now sit at $98.23 — below both analyst targets and the stock's own recent highs. The same JP…
CIB walks into today's print having already recovered from the dip that followed the August 3 report, closing at $91.47 Monday — up nearly 3% on the day and 10% higher over the past month — yet still trading well above…
Snapshot as of 21 Sept 2026
CIB heads into its August 10 earnings report having already delivered one print this cycle — the question now is whether the stock can sustain a level that has moved ahead of most analyst targets. The setup has shifted…
CIB heads into its August 3 earnings report having done something rare: it outran the analysts covering it. The standout development is Goldman Sachs. On July 28, Tito Labarta upgraded CIB to Buy and lifted the price…
Options traders are hedging into CIB's August earnings. Short sellers, meanwhile, have largely exited. The put-call ratio hit 0.6479 on July 20. That is the highest in three weeks. More significantly, it sits 3.65…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CIB — free to start on ORTEX.
Sign up for free →Open CIB on ORTEX